Percentage of defective embryos injected with the reagents indicated in Figure 3A-Bii
| . | Total defects . | ISV defects . | Venus plexus malformation . | Edema . | N . | n . |
|---|---|---|---|---|---|---|
| Control | 0.67% | 0.00% | 0.00% | 0.67% | 3 | 269 |
| ZNF24 | 78.24% (P = .0001) | 48.16% (P = .006) | 58.28% (P = .005) | 58.69% (P = .0006) | 3 | 246 |
| VEGF MO | 97.23% (P = 3.31 × 10−8) | 92.16% (P = 1.23 × 10−5) | 74.93% (P = .001) | 53.62% (P = .01) | 3 | 268 |
| . | Total defects . | ISV defects . | Venus plexus malformation . | Edema . | N . | n . |
|---|---|---|---|---|---|---|
| Control | 0.67% | 0.00% | 0.00% | 0.67% | 3 | 269 |
| ZNF24 | 78.24% (P = .0001) | 48.16% (P = .006) | 58.28% (P = .005) | 58.69% (P = .0006) | 3 | 246 |
| VEGF MO | 97.23% (P = 3.31 × 10−8) | 92.16% (P = 1.23 × 10−5) | 74.93% (P = .001) | 53.62% (P = .01) | 3 | 268 |
N indicates the number of experimental repeats; and n, the total number of embryos injected.